Combined Bachelor's + Master's degree in Medicine and Surgery

Combined Bachelor's + Master's degree in Medicine and Surgery


Course code
Academic sector

Learning outcomes

im of the course is education in pharmacology, i.e. reach a firm understanding that a drug is a tool intended to modify the wellbeing of the patients by interacting with molecular components of the cells and tissues. This interaction leads to modulation of physiological and pathological processes responsible of health and disease.
The student will learn to use his/her knowledge in basic biomedical sciences with the goal of understanding the mechanism of action of a compound and the generation of therapeutic and toxic effects and adverse reactions.
The student will appreciate the links connecting the effects (beneficial and adverse) with the plasmatic levels of a drug. Accordingly, he will learn the basic principles guiding the generation of plasma levels and their temporal changes and the effects of individual properties (genetic, metabolic, presence of diseases) on these dinamic changes.
During the course teachers and students will explore the proprties (mechanisms of action, therapeutic, adverse rections, pharmacokinetic) of classes of drugs active on the Nervous System (Central, Periferal and Autonomic), on the Cardiovascular, the gastrointestinal and the endocrine systems; the pharmacological modulation of inflammatory, immune, infective and oncological processes will also be addressed.

Aims of the General and Clinical Pharmacology module
At the end of the module the student will:
• know the rationale of therapies in order to select and use drugs on the basis of the pathology, the health of the patient, the scientific evidences of effectivness. He/she will also be able to monitor the efficacy of the therapy, the generation of positive symptoms and of adverse reactions.
• know the classification of drugs also in the context of the National Health System, how to prescribe a drug and the use of appropriate data bases also in the context of the Italian National Health System.
• kown the preclinical and clinical development of drugs, the organization of clinical studies and will be able to critically read the results of clinical studies and the use of their results in the daily practice
• understand the basic pharmacodynamic principles governing drug-receptor interaction and the generation of the effects with focus on signal transduction generated by activation/inhibition of drug receptors such as enzymes, ion channels, receptors for endogenous mediators with special interest to ligand activated ion-channel, G protein coupled receptors and intracellular receptors.
• understand the basic principles of pharmacokinetics
• know how to use pharmacokinetic criteria and data to establish individualized therapeutic regimens
• know for each class of drug the mechanism(s) of action and the symptoms generated in order to monitor efficacy and possible toxicity of the therapy;
• know the major differences between drugs belonging to a same class of drugs and the criteria for the selection for individualized therapy
• know the pharmacological properties, as described above, of the following classes of drugs:
• active on the autonomic, peripheral and central nervous system
• used in pulmunary diseases
• active on the cardivascular system
• active on the metabolic/endocrine systems
• used for the control of infectious diseases
• use to control inflammatory conditions
• active on the immunesystem
• used in oncology

Aims of the Pharmacosurveillance module
At the end of the module the student will:
• Understand the etiopathogenetic mechanisms of adverse drug reactions
• Understand the international classification of adverse drug reactions
• Know the main epidemiological data on adverse drug reactions
• Know the most important methods for the study of drug safety
• Know to fill out a report of adverse drug reaction

© 2002 - 2020  Verona University
Via dell'Artigliere 8, 37129 Verona  |  P. I.V.A. 01541040232  |  C. FISCALE 93009870234
Statistics  |  Credits